drugset / Trial / NCT06120803

Esomeprazole and Radiation Induced Esophagitis

NCT06120803

Phase 2 Recruiting 48 enrolled Rush University Medical Center
NaSingle-groupOpen-labelTreatment

Summary

Thoracic radiation therapy combined with chemotherapy (with or without immunotherapy) is the cornerstone of management in patients with locally advanced non-small cell lung cancer (NSCLC).

Timeline

Start
2024-03-01
Primary completion
2027-12-30
Completion
2028-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg